BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 26535366)

  • 1. Clinical Outcome 3 Years After Autologous Chondrocyte Implantation Does Not Correlate With the Expression of a Predefined Gene Marker Set in Chondrocytes Prior to Implantation but Is Associated With Critical Signaling Pathways.
    Stenberg J; de Windt TS; Synnergren J; Hynsjö L; van der Lee J; Saris DB; Brittberg M; Peterson L; Lindahl A
    Orthop J Sports Med; 2014 Sep; 2(9):2325967114550781. PubMed ID: 26535366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro chondrogenic potency of surplus chondrocytes from autologous transplantation procedures does not predict short-term clinical outcomes.
    Islam A; Fossum V; Hansen AK; Urbarova I; Knutsen G; Martinez-Zubiaurre I
    BMC Musculoskelet Disord; 2019 Jan; 20(1):19. PubMed ID: 30630436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In-vitro chondrogenic potential of synovial stem cells and chondrocytes allocated for autologous chondrocyte implantation - a comparison : Synovial stem cells as an alternative cell source for autologous chondrocyte implantation.
    Kubosch EJ; Heidt E; Niemeyer P; Bernstein A; Südkamp NP; Schmal H
    Int Orthop; 2017 May; 41(5):991-998. PubMed ID: 28124102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective study of autologous chondrocyte implantation in patients with failed prior treatment for articular cartilage defect of the knee: results of the Study of the Treatment of Articular Repair (STAR) clinical trial.
    Zaslav K; Cole B; Brewster R; DeBerardino T; Farr J; Fowler P; Nissen C;
    Am J Sports Med; 2009 Jan; 37(1):42-55. PubMed ID: 18927254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An ex vivo human cartilage repair model to evaluate the potency of a cartilage cell transplant.
    Bartz C; Meixner M; Giesemann P; Roël G; Bulwin GC; Smink JJ
    J Transl Med; 2016 Nov; 14(1):317. PubMed ID: 27846904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of the autologous chondrocyte quality of matrix-based autologous chondrocyte implantation in the knee joint.
    Niethammer TR; Limbrunner K; Betz OB; Gülecyüz MF; Pietschmann MF; Feist M; Müller PE
    Int Orthop; 2016 Jan; 40(1):205-12. PubMed ID: 26108176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell carriers as the next generation of cell therapy for cartilage repair: a review of the matrix-induced autologous chondrocyte implantation procedure.
    Brittberg M
    Am J Sports Med; 2010 Jun; 38(6):1259-71. PubMed ID: 19966108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in autologous chondrocyte implantation and related techniques for cartilage repair.
    Foldager CB
    Dan Med J; 2013 Apr; 60(4):B4600. PubMed ID: 23651721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autologous chondrocyte implantation and osteochondral cylinder transplantation in cartilage repair of the knee joint. A prospective, comparative trial.
    Horas U; Pelinkovic D; Herr G; Aigner T; Schnettler R
    J Bone Joint Surg Am; 2003 Feb; 85(2):185-92. PubMed ID: 12571292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autologous bone marrow-derived mesenchymal stem cells versus autologous chondrocyte implantation: an observational cohort study.
    Nejadnik H; Hui JH; Feng Choong EP; Tai BC; Lee EH
    Am J Sports Med; 2010 Jun; 38(6):1110-6. PubMed ID: 20392971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased Chondrocytic Gene Expression Is Associated With Improved Repair Tissue Quality and Graft Survival in Patients After Autologous Chondrocyte Implantation.
    Ackermann J; Merkely G; Mestriner AB; Shah N; Gomoll AH
    Am J Sports Med; 2019 Oct; 47(12):2919-2926. PubMed ID: 31433670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maintenance of human chondrogenic phenotype on a dendrimer-immobilized surface for an application of cell sheet engineering.
    Wongin S; Waikakul S; Chotiyarnwong P; Siriwatwechakul W; Kino-Oka M; Kim MH; Viravaidya-Pasuwat K
    BMC Biotechnol; 2018 Mar; 18(1):14. PubMed ID: 29540167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased TGF-β and BMP Levels and Improved Chondrocyte-Specific Marker Expression In Vitro under Cartilage-Specific Physiological Osmolarity.
    Tan Timur U; Caron M; van den Akker G; van der Windt A; Visser J; van Rhijn L; Weinans H; Welting T; Emans P; Jahr H
    Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30781744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RNA Interference and BMP-2 Stimulation Allows Equine Chondrocytes Redifferentiation in 3D-Hypoxia Cell Culture Model: Application for Matrix-Induced Autologous Chondrocyte Implantation.
    Rakic R; Bourdon B; Hervieu M; Branly T; Legendre F; Saulnier N; Audigié F; Maddens S; Demoor M; Galera P
    Int J Mol Sci; 2017 Aug; 18(9):. PubMed ID: 28837082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improvement of the Chondrocyte-Specific Phenotype upon Equine Bone Marrow Mesenchymal Stem Cell Differentiation: Influence of Culture Time, Transforming Growth Factors and Type I Collagen siRNAs on the Differentiation Index.
    Branly T; Contentin R; Desancé M; Jacquel T; Bertoni L; Jacquet S; Mallein-Gerin F; Denoix JM; Audigié F; Demoor M; Galéra P
    Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29389887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recommendations and treatment outcomes for patellofemoral articular cartilage defects with autologous chondrocyte implantation: prospective evaluation at average 4-year follow-up.
    Pascual-Garrido C; Slabaugh MA; L'Heureux DR; Friel NA; Cole BJ
    Am J Sports Med; 2009 Nov; 37 Suppl 1():33S-41S. PubMed ID: 19861699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chondroprotective effects of taurine in primary cultures of human articular chondrocytes.
    Liu Q; Lu Z; Wu H; Zheng L
    Tohoku J Exp Med; 2015 Mar; 235(3):201-13. PubMed ID: 25765089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autologous Chondrocyte Implantation in Osteoarthritic Surroundings: TNFα and Its Inhibition by Adalimumab in a Knee-Specific Bioreactor.
    Ossendorff R; Grad S; Stoddart MJ; Alini M; Schmal H; Südkamp N; Salzmann GM
    Am J Sports Med; 2018 Feb; 46(2):431-440. PubMed ID: 29100004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Equivalent 10-Year Outcomes After Implantation of Autologous Bone Marrow-Derived Mesenchymal Stem Cells Versus Autologous Chondrocyte Implantation for Chondral Defects of the Knee.
    Teo AQA; Wong KL; Shen L; Lim JY; Toh WS; Lee EH; Hui JHP
    Am J Sports Med; 2019 Oct; 47(12):2881-2887. PubMed ID: 31433674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defect type, localization and marker gene expression determines early adverse events of matrix-associated autologous chondrocyte implantation.
    Angele P; Fritz J; Albrecht D; Koh J; Zellner J
    Injury; 2015 Oct; 46 Suppl 4():S2-9. PubMed ID: 26542862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.